TAXOTERE

This brand name is authorized in Austria, Brazil, Cyprus, Ecuador, Estonia, Spain, France, Hong Kong, Ireland, Japan, Lithuania, Mexico, Nigeria, Netherlands, Poland, Tunisia, United States

Active ingredients

The drug TAXOTERE contains one active pharmaceutical ingredient (API):

1 Docetaxel trihydrate
UNII 15H5577CQD - DOCETAXEL

Docetaxel is an antineoplastic agent which acts by promoting the assembly of tubulin into stable microtubules and inhibits their disassembly which leads to a marked decrease of free tubulin.

Read about Docetaxel

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
Taxotere 20mg/1ml concentrate for solution for infusion Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
L01CD02 Docetaxel L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01C Plant alkaloids and other natural products → L01CD Taxanes
Discover more medicines within L01CD02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 502812603158319, 502812604154317, 576720080084017, 576720080084117
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): H3020113, H3030113
Country: EE Ravimiamet Identifier(s): 1028809, 1118843, 1455825, 1455836, 1476952
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 95002003, 95002004, 95002005
Country: FR Base de données publique des médicaments Identifier(s): 60385433, 60509781, 68257752
Country: HK Department of Health Drug Office Identifier(s): 41353, 41354
Country: JP 医薬品医療機器総合機構 Identifier(s): 4240405A1037, 4240405A2033
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1003176, 1003177, 1005304, 1005305, 1005573, 1005574, 1064326
Country: MX Comisión Federal para la Protección contra Riesgos Sanitarios Identifier(s): 533M94
Country: NG Registered Drug Product Database Identifier(s): B4-4447
Country: NL Z-Index G-Standaard Identifier(s): 13998269, 14899418
Country: NL Z-Index G-Standaard, PRK Identifier(s): 92851, 92878
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100065841, 100205615, 100217860, 100332822, 100332839
Country: SG Health Sciences Authority Identifier(s): 14106P, 14107P
Country: TN Direction de la Pharmacie et du Médicament Identifier(s): 8903013H, 8903014H
Country: US FDA, National Drug Code Identifier(s): 0075-8004

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.